ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2310

Enhancement of CRACM1 Expression in Functionally Aberrant Naïve CD4+ T Cells in Active Rheumatoid Arthritis

Shuang Liu1, Shohei Watanabe2, Miyuki Kuno3, Hiromasa Miura2 and Kazutaka Maeyama1, 1Department of Pharmacology, Informational Biomedicine, Ehime University Graduate School of Medicine, Toon-shi, Ehime, Japan, 2Department of Bone and Joint Surgery, Ehime University Graduate School of Medicine, Toon, Japan, 3Department of Molecular and Cellular Physiology, Osaka City University Graduate School of Medicine, Osaka, Japan

Meeting: 2012 ACR/ARHP Annual Meeting

Keywords: CD T cells

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: T-cell Biology and Targets in Autoimmune Disease

Session Type: Abstract Submissions (ACR)

Background/Purpose: Lymphocytes from rheumatoid arthritis (RA) patients have been reported to exhibit increased basal intracellular Ca2+ concentrations compared with the lymphocytes of healthy controls.  A precise molecular explanation for the enhanced Ca2+ influx in T cells has not yet been established. To explore the molecular basis of the irregular Ca2+ influx in RA T cells, we performed a cross-sectional study to characterise the expression levels and functional status of Ca2+ release-activated Ca2+ (CRAC) channels in peripheral naïve CD4+ T cells from 50 RA patients, 50 osteoarthritis (OA) patients and 15 healthy donors.

Methods: To determine whether CRACM1 channels contribute to the abnormal behavior of T cells in RA, CRACM1 expression was evaluated by western blotting and immunofluorescence analysis. We also measured Ca2+ influx and CRAC currents in naïve CD4+ T cells, as well as cytokine release by activated naïve CD4+ T cells, for each of the three groups.

Results: 1.Intracellular Ca2+ influx is up-regulated in naïve CD4+ T cells from RA patients and is associated with RA disease activity.2 .CRACM1 channel function is increased in T cells from active RA patients. 3.CRACM1 expression in naïve CD4+ T cells is higher in active RA patients than in OA patients and healthy donors.  

 Conclusion: Functionally aberrant naïve CD4+ T cells from active RA patients exhibited an increase in Ca2+ influx, as well as up-regulated CRACM1 protein expression and function, indicating that CRACM1 might represent a new molecular target for novel RA therapies.


Disclosure:

S. Liu,
None;

S. Watanabe,
None;

M. Kuno,
None;

H. Miura,
None;

K. Maeyama,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2012 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/enhancement-of-cracm1-expression-in-functionally-aberrant-naive-cd4-t-cells-in-active-rheumatoid-arthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology